我们应该在什么时候对患有风湿性疾病的儿童使用肿瘤坏死因子拮抗剂？ - Suppr

Suppr

超能文献

When should we use TNF antagonists in children with rheumatic disease?

作者信息

Quartier Pierre

出版信息

Joint Bone Spine. 2007 Jan;74(1):1-3. doi: 10.1016/j.jbspin.2006.07.001. Epub 2006 Nov 13.

DOI:10.1016/j.jbspin.2006.07.001

PMID:17174585

Abstract

摘要

相似文献

When should we use TNF antagonists in children with rheumatic disease?

Joint Bone Spine. 2007 Jan;74(1):1-3. doi: 10.1016/j.jbspin.2006.07.001. Epub 2006 Nov 13.

Trials reveal promising options for treating juvenile rheumatoid arthritis.

JAMA. 2008 Jan 2;299(1):27-8. doi: 10.1001/jama.2007.36.

[Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].

Med Clin (Barc). 2010 May 22;134(15):684-5. doi: 10.1016/j.medcli.2009.12.003. Epub 2010 Feb 21.

Juvenile idiopathic arthritis: current and future treatment options.

Expert Opin Pharmacother. 2006 Mar;7(4):387-99. doi: 10.1517/14656566.7.4.387.

Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.

Paediatr Drugs. 2010 Dec 1;12(6):367-77. doi: 10.2165/11532610-000000000-00000.

Which TNF inhibitor for rheumatoid arthritis?

Med Lett Drugs Ther. 2010 May 17;52(1338):38-9.

[Biological therapy treatment of juvenile idiopathic arthritis].

Ugeskr Laeger. 2008 Jun 9;170(24):2105-8.

[Anti-TNF therapy in rheumatoid arthritis].

Nihon Rinsho Meneki Gakkai Kaishi. 2004 Feb;27(1):7-15. doi: 10.2177/jsci.27.7.

[Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 1. TNF inhibitors].

Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):2966-71. doi: 10.2169/naika.100.2966.

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):31-8. Epub 2012 Mar 6.

引用本文的文献

Growth retardation and delayed puberty in children and adolescents with juvenile idiopathic arthritis.

Arch Med Sci. 2010 Mar 1;6(1):19-23. doi: 10.5114/aoms.2010.13501. Epub 2010 Mar 9.

Biologics in children's autoimmune disorders: efficacy and safety.

Eur J Pediatr. 2011 Feb;170(2):157-67. doi: 10.1007/s00431-010-1238-z. Epub 2010 Jun 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

When should we use TNF antagonists in children with rheumatic disease?

Joint Bone Spine. 2007 Jan;74(1):1-3. doi: 10.1016/j.jbspin.2006.07.001. Epub 2006 Nov 13.

Trials reveal promising options for treating juvenile rheumatoid arthritis.

JAMA. 2008 Jan 2;299(1):27-8. doi: 10.1001/jama.2007.36.

[Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].

Med Clin (Barc). 2010 May 22;134(15):684-5. doi: 10.1016/j.medcli.2009.12.003. Epub 2010 Feb 21.

Juvenile idiopathic arthritis: current and future treatment options.

Expert Opin Pharmacother. 2006 Mar;7(4):387-99. doi: 10.1517/14656566.7.4.387.

Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.

Paediatr Drugs. 2010 Dec 1;12(6):367-77. doi: 10.2165/11532610-000000000-00000.

Which TNF inhibitor for rheumatoid arthritis?

Med Lett Drugs Ther. 2010 May 17;52(1338):38-9.

[Biological therapy treatment of juvenile idiopathic arthritis].

Ugeskr Laeger. 2008 Jun 9;170(24):2105-8.

[Anti-TNF therapy in rheumatoid arthritis].

Nihon Rinsho Meneki Gakkai Kaishi. 2004 Feb;27(1):7-15. doi: 10.2177/jsci.27.7.

[Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 1. TNF inhibitors].

Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):2966-71. doi: 10.2169/naika.100.2966.

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):31-8. Epub 2012 Mar 6.

引用本文的文献

Growth retardation and delayed puberty in children and adolescents with juvenile idiopathic arthritis.

Arch Med Sci. 2010 Mar 1;6(1):19-23. doi: 10.5114/aoms.2010.13501. Epub 2010 Mar 9.

Biologics in children's autoimmune disorders: efficacy and safety.

Eur J Pediatr. 2011 Feb;170(2):157-67. doi: 10.1007/s00431-010-1238-z. Epub 2010 Jun 17.